Clinical Trials Browser

Phase 2 × Carcinoma, Renal Cell × irofulven × Clear all

NCT00003390 2013-06-21

6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer

Phase 2 Completed

Carcinoma, Renal Cell, Kidney Neoplasms